Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 20

    1.

    Toxicity Assessment of intravitreal Triamcinolone and Bevacizumab in an retinal explant mouse model using Two-Photon Microscopy.

    Schlichtenbrede FC, Mittmann W, Rensch F, Vom Hagen F, Jonas JB, Euler T.

    Invest Ophthalmol Vis Sci. 2009 Jul 2. [Epub ahead of print]PMID: 19578025 [PubMed - as supplied by publisher]Related articles

    2.

    Intravitreal bevacizumab for neovascular glaucoma.

    Jonas JB, Golubkina L, Libondi T, Rensch F.

    Acta Ophthalmol. 2009 Jun 10. [Epub ahead of print] No abstract available. PMID: 19519731 [PubMed - as supplied by publisher]Related articles

    3.

    Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.

    Jonas JB, Libondi T, Golubkina L, Spandau UH, Schlichtenbrede F, Rensch F.

    Acta Ophthalmol. 2009 Apr 27. [Epub ahead of print]PMID: 19432871 [PubMed - as supplied by publisher]Related articles

    4.

    Diabetic macular edema.

    Jonas J, Rensch F.

    Ophthalmology. 2009 Mar;116(3):594-5; author reply 596-7. No abstract available. PMID: 19264219 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.

    Rensch F, Spandau UH, Wickenhäuser A, Jonas JB.

    Acta Ophthalmol. 2009 Feb 6. [Epub ahead of print] No abstract available. PMID: 19210330 [PubMed - as supplied by publisher]Related articles

    6.

    Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion.

    Rensch F, Jonas JB, Spandau UH.

    Ophthalmologica. 2009;223(2):124-7. Epub 2008 Dec 17.PMID: 19088494 [PubMed - indexed for MEDLINE]Related articles

    7.

    Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.

    Rensch F, Jonas JB, Spandau UH.

    Acta Ophthalmol. 2009 Feb;87(1):77-81. Epub 2008 Oct 17.PMID: 18937800 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal steroid slow-release device replacing repeated intravitreal triamcinolone injections for sympathetic ophthalmia.

    Jonas JB, Rensch F.

    Eur J Ophthalmol. 2008 Sep-Oct;18(5):834-6.PMID: 18850570 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Multiple familiar trichoepithelioma (Brooke's syndrome) : A rare autosomal dermatosis with possible periocular manifestation]

    Rensch F, Harder B, Goebeler M, Back W, Jonas JB, Schlichtenbrede F.

    Ophthalmologe. 2009 Aug;106(8):735-6, 738-9. German. PMID: 18830600 [PubMed - indexed for MEDLINE]Related articles

    10.

    Direct microperimetry of alpha zone and beta zone parapapillary atrophy.

    Rensch F, Jonas JB.

    Br J Ophthalmol. 2008 Dec;92(12):1617-9. Epub 2008 Sep 9.PMID: 18782800 [PubMed - indexed for MEDLINE]Related articles

    11.

    Microperimetric changes after intravitreal bevacizumab for exudative age-related macular degeneration.

    Rensch F, Jonas JB.

    Acta Ophthalmol. 2008 Sep;86(6):696-7. No abstract available. PMID: 18752522 [PubMed - indexed for MEDLINE]Related articles

    12.

    Progression of tractional retinal detachment following intravitreal bevacizumab.

    Jonas JB, Schmidbauer M, Rensch F.

    Acta Ophthalmol. 2009 Aug;87(5):571-2. Epub 2008 Jul 9. No abstract available. PMID: 18631336 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab for myopic choroidal neovascularization.

    Rensch F, Spandau UH, Schlichtenbrede F, von Baltz S, Libondi T, Jonas JB, Vossmerbaeumer U.

    Ophthalmic Surg Lasers Imaging. 2008 May-Jun;39(3):182-5.PMID: 18556936 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ophthalmodynamometric measurement of central retinal vein pressure as surrogate of intracranial pressure in idiopathic intracranial hypertension.

    Jonas JB, Pfeil K, Chatzikonstantinou A, Rensch F.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):1059-60. Epub 2008 Feb 15.PMID: 18274770 [PubMed - indexed for MEDLINE]Related articles

    15.

    Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions.

    Jonas JB, Rensch F.

    Br J Ophthalmol. 2007 Dec;91(12):1711-2. No abstract available. PMID: 18024817 [PubMed - indexed for MEDLINE]Related articles

    16.

    Infectious and noninfectious endophthalmitis after intravitreal bevacizumab.

    Jonas JB, Spandau UH, Rensch F, Von Baltz S, Schlichtenbrede F.

    J Ocul Pharmacol Ther. 2007 Jun;23(3):240-2.PMID: 17593007 [PubMed - indexed for MEDLINE]Related articles

    17.

    Peripapillary atrophy after acute primary angle closure.

    Lee KY, Rensch F, Aung T, Lim LS, Husain R, Gazzard G, Seah SK, Jonas JB.

    Br J Ophthalmol. 2007 Aug;91(8):1059-61. Epub 2007 Feb 27.PMID: 17327265 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal bevacizumab for branch retinal vein occlusion.

    Spandau U, Wickenhäuser A, Rensch F, Jonas J.

    Acta Ophthalmol Scand. 2007 Feb;85(1):118-9. No abstract available. PMID: 17244225 [PubMed - indexed for MEDLINE]Related articles

    19.

    The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.

    Trojan L, Rensch F, Voss M, Grobholz R, Weiss C, Jackson DG, Alken P, Michel MS.

    BJU Int. 2006 Oct;98(4):903-6.PMID: 16978291 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...